Location · Bangor, ME
Clinical trials in Bangor, ME
6 recruiting studies have a site in Bangor, and 1 of them accept healthy volunteers.
6 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 3
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Cytokinetics
- Location
- Bangor, ME + 80 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingPhase 3
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
GlaxoSmithKline
- Location
- Bangor, ME + 50 other US sites
- Eligibility basics
- Ages 40–80
- RecruitingPhase 3
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
GlaxoSmithKline
- Location
- Bangor, ME + 37 other US sites
- Eligibility basics
- Ages 40–75
- RecruitingPhase 3
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Anthos Therapeutics, Inc.
- Location
- Bangor, ME + 131 other US sites
- Eligibility basics
- Ages 65+
- RecruitingPhase 3
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
DalCor Pharmaceuticals
- Location
- Bangor, ME + 112 other US sites
- Eligibility basics
- Ages 45+
- RecruitingHealthy volunteers
Improving Health Outcomes Through Investigations of Wabanaki Food Systems in Maine
Wabanaki Public Health and Wellness
- Location
- Bangor, ME
- Eligibility basics
- Ages 18+